In vitro activity of ertapenem against bacterial isolates from cancer patients

Clicks: 371
ID: 116976
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #12 of 48 articles by views in Diagnostic microbiology and infectious disease

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In vitro activity of ertapenem against bacterial isolates from cancer patients
Reference Key
kv2002diagnosticin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rolston KV;LeBlanc BM;Streeter H;Ho DH;;
Journal Diagnostic microbiology and infectious disease
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12106955
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't microbial sensitivity tests anti-bacterial agents / pharmacology* bacteria / isolation & purification bacterial infections / microbiology* beta-lactams staphylococcus / drug effects neoplasms / complications streptococcus / drug effects gram-negative bacteria / drug effects bacteria / drug effects* gram-positive bacteria / drug effects pmid:12106955 doi:10.1016/s0732-8893(02)00395-4 kenneth v i rolston barbara m leblanc dah h ho ertapenem lactams* neoplasms / microbiology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.